Virology and Antimicrobial Agents: Core Concepts for Microbiology

Virology

Introduction to Virology

Virology is the study of viruses, which are unique infectious agents that impact all forms of life. Viruses are non-cellular particles that require a host cell for replication and have significant effects on their hosts and ecosystems.

• Virus Definition: A virus is a non-cellular particle containing a genome (DNA or RNA) and lacking independent metabolism. It is an obligate intracellular parasite.

• Virion: The complete, extracellular form of a virus.

• Host Range: Viruses infect all cellular life forms, including bacteria (bacteriophages), plants, animals, algae, insects, and archaea.

Historical Perspective

The discovery of viruses began with studies on plant diseases and progressed to the identification of viruses affecting animals and humans.

• Ivanowski (1892): Demonstrated that infectious agents smaller than bacteria could cause disease in plants.

• Beijerinck: Showed that the agent could reproduce only in a host, coining the term "virus" (Latin for poison or venom).

• First Virus Discovered: Tobacco mosaic virus (TMV).

• Bacteriophage Discovery (1915): Viruses that infect bacteria were identified.

Virus Structure

Viruses exhibit diverse morphologies and structural components, which are crucial for their infectivity and classification.

• Nucleic Acid: DNA or RNA, single- or double-stranded.

• Capsid: Protein coat composed of capsomers; protects the viral genome.

• Envelope: Lipid bilayer derived from the host cell, present in some viruses.

• Spike Proteins: Glycoproteins on the envelope or capsid, involved in host cell recognition and entry.

• Accessory Proteins: May aid in entry, release, or genome replication (e.g., lysozyme-like enzymes, neuraminidases).

Virus Shapes and Sizes

Viruses vary widely in size (20–300 nm, some up to 1,000 nm) and shape, which influences their classification and infection mechanisms.

• Rod-shaped (Filamentous/Helical): e.g., Ebola virus, TMV.

• Spherical (Icosahedral): e.g., Herpes simplex virus.

• Complex: e.g., T4 bacteriophage (icosahedral head, helical tail, tail fibers).

• Other Shapes: Giant viruses like Mimivirus (infects protozoa, ~700 nm diameter).

Viral Genomes

Viral genomes are highly diverse in structure and composition, affecting replication strategies and host interactions.

• Genome Size: 2 to 1,000 genes.

• Types:

  • Single-stranded DNA (ssDNA)

  • Double-stranded DNA (dsDNA)

  • Single-stranded RNA (ssRNA)

  • Double-stranded RNA (dsRNA)

• General Trends:

  • Most DNA viruses are dsDNA.

  • Most RNA viruses are ssRNA.

  • dsDNA common in bacterial viruses; ssRNA common in plant viruses; all types found in animal viruses.

• Genome Structure: DNA may be linear or circular; RNA is always linear and may be segmented.

Virus Cultivation and Quantification

Viruses are cultivated using host cells, and their quantity is measured by plaque assays.

• Bacteriophage Cultivation: Mix phage with host bacteria in soft agar, pour onto agar plate, incubate. Clear zones (plaques) indicate cell lysis.

• Plaque-Forming Units (PFU): Used to quantify infectious virus particles. Not all virions are infective.

• Animal Virus Cultivation: Use tissue cultures; plaques may be visualized with stains.

• Plant Virus Cultivation: Plant cells have thick walls, so plaques are not formed; other methods are used.

General Steps in Viral Infection

Viral infection follows a series of steps, leading to the production and release of new virions.

1. Attachment: Virus binds to host cell surface.

2. Penetration: Viral genome enters the host cell (injection for bacteriophages; endocytosis or fusion for animal viruses).

3. Synthesis: Viral nucleic acid and proteins are synthesized using host machinery.

4. Assembly: New virions are assembled from synthesized components.

5. Release: Virions exit the host cell, often causing cell lysis or budding.

Chemical Antimicrobial Agents

Types of Antimicrobial Agents

Chemical agents are used to control microbial growth and infection. Their effectiveness and selectivity are crucial for safe and effective use.

• Disinfectants: Chemicals that destroy most microbes on non-living surfaces.

• Sterilants: Agents that kill all forms of microbial life, including spores.

• Chemotherapeutic Agents: Drugs used to treat infections within the body.

• Bactericidal vs. Bacteriostatic:

  • Bactericidal: Kills bacteria.

  • Bacteriostatic: Inhibits bacterial growth without killing.

• Effectiveness Measurement:

  • Zone of Inhibition: Area around an antimicrobial agent where bacteria do not grow.

  • Minimum Inhibitory Concentration (MIC): Lowest concentration of an agent that prevents visible growth.

• Desirable Properties:

  • High selective toxicity (targets pathogen, not host).

  • Narrow-spectrum activity (minimizes impact on beneficial microbes).

  • Reduces risk of antibiotic resistance.

Modes of Action of Antibiotics

Antibiotics target specific cellular processes in microbes, leading to inhibition or death.

• Nucleic Acid Synthesis Inhibitors: Block DNA or RNA synthesis (e.g., quinolones, rifampin).

• Cell Wall Synthesis Inhibitors: Prevent formation of peptidoglycan (e.g., penicillins, cephalosporins).

• Protein Synthesis Inhibitors: Interfere with ribosomal function (e.g., tetracyclines, aminoglycosides).

• Membrane Disruptors: Damage cell membrane integrity (e.g., polymyxins).

• Growth Factor Analogs: Mimic essential nutrients, disrupting metabolic pathways (e.g., sulfonamides).

Antibiotic Resistance Mechanisms

Bacteria can develop resistance to antibiotics through various mechanisms, threatening effective treatment.

• Active Efflux: Efflux pumps expel antibiotics from the cell.

• Target Protection: Proteins protect antibiotic targets from drug action.

• Antibiotic-Modifying Enzymes: Enzymes chemically modify or inactivate antibiotics.

• Target Site Modification: Alteration of antibiotic binding sites reduces drug efficacy.

• Target Bypass: Bacteria use alternative metabolic pathways.

• Decreased Influx: Reduced permeability limits antibiotic entry.

• Downregulation of Porins: Fewer porin channels decrease antibiotic uptake.

Summary Table: Antibiotic Resistance Mechanisms

Mechanism	Description	Example
Active Efflux	Pumps expel antibiotics from cell	Tetracycline resistance
Target Protection	Proteins shield antibiotic targets	Qnr proteins for quinolones
Antibiotic Modification	Enzymes inactivate antibiotics	β-lactamases for penicillins
Target Site Modification	Altered binding sites	MRSA (altered penicillin-binding proteins)
Target Bypass	Alternative metabolic pathways	Trimethoprim resistance
Decreased Influx	Reduced permeability	Porin loss in Gram-negative bacteria

Key Equations

• Minimum Inhibitory Concentration (MIC): $MIC = \text{Lowest concentration of antimicrobial agent that inhibits visible growth}$

• Plaque-Forming Units (PFU): $PFU/mL = \frac{\text{Number of plaques}}{\text{Volume plated (mL)}}$

Additional info:

• Viruses are not considered truly "alive" because they cannot replicate independently of a host cell.

• Some plant viruses may confer beneficial traits, such as drought tolerance.